|
Dr. Brettman has served as a member of our board of directors since November 2002. Dr. Brettman is the president and chief executive officer of Dynogen Pharmaceuticals a company which he founded in 2002. From 2001 to 2002 Dr. Brettman was an entrepreneur in residence at Oxford Bioscience Partners a venture capital firm. From 1995 to 1999 he was chief medical officer and senior vice president of medical and regulatory affairs at Leukosite Inc. and then held the same positions from 1999 to 2001 at Millennium Pharmaceuticals Inc. both biopharmaceutical companies. Dr. Brettman received an M.D. from the Baylor College of Medicine and two bachelors degrees from the Massachusetts Institute of Technology. | 